GLP-1 Formulary Tier Explained: What Your Insurance Tier Actually Means
What Tier 1, 2, 3, 4, and “specialty” mean for Ozempic, Wegovy, Zepbound, and Foundayo — and the one question to ask your plan next.
Your insurance just hit you with a word — “Tier 3,” “specialty,” “prior authorization,” or the scary one, “non-formulary” — and your stomach dropped. You’re not bad at this. The system is genuinely confusing. Let’s fix it in the next five minutes.
Here’s the GLP-1 formulary tier explained in plain English: a formulary is your plan’s list of covered drugs, and a tier is the price bucket your plan puts each drug in. Lower tiers cost you less. Higher tiers cost you more. Brand-name GLP-1s like Ozempic, Wegovy, Zepbound, and Mounjaro commonly sit in a higher-cost brand tier or a specialty tier — and often come with extra paperwork, especially when prescribed for weight loss.
Here’s the part that surprises everyone: your tier number alone does not tell you your final price. Three things decide your real cost: your specific plan, your diagnosis (diabetes coverage is more common; weight-loss-only coverage is often restricted or excluded), and whether your plan charges a flat copay or a percentage called coinsurance.
Quick decoder — find what your plan said
Find your label, see what it really means, and get the one question to ask next. Last verified .
| If your plan says… | What it usually means | What it does NOT prove | Your next move |
|---|---|---|---|
| Tier 1 or 2 | A lower-cost tier on that plan | That a GLP-1 is on it, or that there's no paperwork | Verify the exact drug, dose, indication, and PA rules |
| Tier 3 | Covered, but higher cost (often non-preferred brand) | Whether it's a flat copay or a percentage | Ask: copay or coinsurance -- and the real 28-day cost? |
| Tier 4 / specialty | A high-cost or specialty bucket; in 5-tier plans, Tier 5 can be higher | That you can afford it -- coinsurance can be steep | Ask for the actual dollar cost of a 28-day fill |
| Prior authorization required | Your insurer wants paperwork first -- not a denial | That you'll be denied | Have your prescriber submit it with the right criteria |
| Step therapy required | You may need to try a cheaper option first | That you can never get this drug | Ask which drug, how long, and what counts as "didn't work" |
| Non-formulary | Not on this plan's covered list | That no path exists | Ask if your prescriber can file a formulary exception |
| Excluded | Won't be covered for that use (common for weight loss) | That it's excluded for every use | Ask: excluded for all uses, or just weight loss? |
GLP-1 formulary tier explained: what does the tier actually tell you?
A GLP-1 formulary tier tells you where your insurance plan files the medication in its cost system — roughly, how cheap or expensive your plan treats it. It does not, on its own, prove your final price, whether prior authorization will be approved, whether your diagnosis qualifies, or how much of your deductible you’ve met. The tier is the starting label, not the final bill.
Think of your formulary like a menu with price zones. Generics sit in the cheap zone. Brand-name drugs sit higher. The most expensive drugs — including most GLP-1s — sit in the specialty zone at the top. Most plans use three, four, or five tiers. The catch: the same tier number means different things on different plans. One plan’s “Tier 3” is another plan’s “Tier 4.”
| What your tier tells you | What it does NOT tell you |
|---|---|
| ✓ The drug exists somewhere in your plan's pricing system | ✕ Your exact copay or coinsurance dollar amount |
| ✓ The rough cost zone (low, medium, high, specialty) | ✕ Whether prior authorization will be approved |
| ✓ Whether you're in a flat-copay or percentage-coinsurance zone (ask!) | ✕ If your diagnosis qualifies for coverage |
| ✓ A rough estimate of where GLP-1s generally land | ✕ Your deductible status or which pharmacy you must use |
Does Tier 2, 3, or 4 mean my GLP-1 is actually covered?
Tier 2, 3, or 4 usually means your GLP-1 appears somewhere in your plan’s cost structure — but “appears” is not the same as “approved and affordable.” A covered GLP-1 can still require prior authorization, and a high tier can still cost hundreds a month if your plan uses coinsurance. Here’s the practical translation, tier by tier:
The hard truth: “covered” is not the finish line. Brand-name GLP-1s commonly sit on higher brand or specialty tiers, prior authorization is common, and weight-loss versions are more likely to be restricted or excluded than diabetes versions. In Ro’s own coverage-checker data, about half of covered patients had a copay of $50 a month or less — but most still had to clear prior authorization first.
Why is my GLP-1 “covered” but still costs hundreds of dollars?
A GLP-1 can be on your formulary and still cost a fortune because the tier only sets the rules — your deductible, your cost-share type, and your pharmacy set the price. The single biggest reason for a shocking bill is coinsurance on a specialty tier, where you pay a percentage of the drug’s price instead of a flat fee.
Copay vs. coinsurance: the critical distinction
A copay is a flat dollar amount — say, $50. You pay $50 whether the drug costs $200 or $2,000. A coinsurance is a percentage of the drug’s price. GLP-1s carry a list price of roughly $1,000–$1,400 a month, depending on the drug.
| Cost-share type | If list price ≈ $1,350/mo | Your monthly out-of-pocket | Notes |
|---|---|---|---|
| Flat $50 copay | $1,350 | $50 | Best-case scenario; not common for specialty-tier GLP-1s |
| 25% coinsurance | $1,350 | ~$337 | Before deductible, savings cards, or your plan's allowed rate |
| 30% coinsurance | $1,350 | ~$405 | Mid-range specialty cost-share |
| 33% coinsurance | $1,350 | ~$445 | Common for higher-tier specialty plans |
| Full cost (deductible not met) | $1,350 | Up to full price | Early in the year before you hit your deductible |
- Deductible not yet met. Early in the year, you may pay full price until you hit it.
- Specialty pharmacy rules. Some plans force you to use one specific pharmacy.
- Savings-card limits. Manufacturer cards can cut costs — but usually only for commercial insurance, and some plans blunt them.
This is the moment to get your real number. Ro’s free GLP-1 Insurance Coverage Checker uses your insurance details to check your insurer and send back a personalized report — your coverage, your estimated cost, and whether prior authorization is required, across several GLP-1s. Free, no need to become a patient.
Check what my plan really covers → (sponsored affiliate link, opens in a new tab)Best fit for commercial or federal (FEHB) insurance. About half of covered patients in Ro’s data had a copay of $50/month or less. Your result depends on your plan.
What do prior authorization, step therapy, quantity limits, and exceptions mean?
These are separate tools your insurer uses to control which GLP-1s it pays for, and they often stack on top of your tier. Knowing which one you’re facing tells you exactly what to do next.
| Term | What it means | What to ask |
|---|---|---|
| Prior authorization (PA) | Your insurer wants documentation that the drug is medically necessary before it pays | "What exact criteria and diagnosis codes do you need for this GLP-1?" |
| Step therapy | You must try (and have a reason to stop) a lower-cost option first | "Which drug first, for how long, and what counts as it not working?" |
| Quantity limit | The plan limits dose, fill amount, or refill timing | "Which strengths are covered, and does each dose need its own PA?" |
| Formulary exception | Request to cover a non-formulary drug because covered options don't fit you | "Can my prescriber file a formulary exception, and what must we rule out first?" |
| Tier exception | Request to charge a covered drug at a lower tier's cost | "Can we request a tier exception to lower my cost-share?" |
| Appeal | A formal challenge after a denial | "What's the appeal deadline, and what should the letter of medical necessity include?" |
- Your diagnosis and ICD-10 code
- BMI documentation, or a weight-related condition like high blood pressure or sleep apnea
- A record of past attempts (diet, lifestyle, or other medications) if step therapy is required
- Your current medications and a safety review
- The exact drug, dose, and sometimes the NDC (the specific product ID number)
Why does my diagnosis matter so much for GLP-1 coverage?
For GLP-1s, why you’re taking the drug often matters more than which drug it is. Plans frequently cover a GLP-1 for Type 2 diabetes, cardiovascular risk, or sleep apnea while restricting or excluding the same drug class when prescribed only for weight loss. This is the rule that explains a thousand confused forum posts (“My friend got Ozempic covered — why won’t they cover my Wegovy?”).
| Diagnosis / indication | Typical coverage situation | Examples |
|---|---|---|
| Type 2 diabetes | Most reliably covered with PA | Ozempic, Mounjaro, Rybelsus |
| Weight loss / obesity only | Most restricted; many employer plans exclude | Wegovy, Zepbound, Saxenda, Foundayo |
| Cardiovascular risk | Can unlock coverage even when weight-loss use is excluded | Wegovy (has FDA CV indication), Ozempic |
| Sleep apnea (OSA) | Opens a coverage path on some plans | Zepbound (has FDA OSA indication) |
| MASH (liver disease) | Niche but separate FDA indication | Wegovy injection |
The data backs this up. In Ro’s coverage-checker report, about 43% of users had coverage for a GLP-1 for weight loss, while nearly all had coverage for a GLP-1 used for Type 2 diabetes. Same drugs. Different reason. Different answer.
What tier are Ozempic, Wegovy, Zepbound, Mounjaro, and the other GLP-1s on?
There is no single universal tier for any GLP-1. The same drug can be preferred on one plan, specialty on another, and excluded on a third. Use this 2026 map to set expectations, then confirm your own number.
| Medication (brand) | FDA-approved use(s) | Typical commercial placement | Medicare in 2026 |
|---|---|---|---|
| Ozempic (semaglutide) | Type 2 diabetes; cardiovascular-risk reduction in adults with T2D and known heart disease | Higher brand or specialty tier; PA common | Covered for diabetes/CV uses with PA; not a Bridge drug |
| Mounjaro (tirzepatide) | Type 2 diabetes | Higher brand or specialty tier; PA common | Covered for diabetes with PA; not a Bridge drug |
| Wegovy (semaglutide) | Obesity/overweight + weight-related condition; CV-risk reduction; noncirrhotic MASH | Specialty tier or excluded for weight loss; PA and BMI criteria | For weight loss: excluded from standard Part D, but Bridge-eligible (all formulations) at $50/mo from July 1, 2026. For CV-risk or MASH: Part D lane (not the Bridge) |
| Zepbound (tirzepatide) | Obesity; moderate-to-severe obstructive sleep apnea in adults with obesity | Specialty tier or excluded for weight loss; PA and BMI criteria | For weight loss: KwikPen is Bridge-eligible at $50/mo from July 1, 2026 (single-dose vial/pen are not). For sleep apnea: Part D lane |
| Rybelsus (oral semaglutide) | Type 2 diabetes | Brand tier; PA / step therapy | Covered for diabetes with PA |
| Saxenda (liraglutide) | Obesity (ages 12+) | Specialty tier or excluded for weight loss | Weight-loss use excluded from standard Part D; not a Bridge drug |
| Foundayo (orforglipron) | Obesity/overweight + weight-related condition (FDA approved April 1, 2026); oral, once daily | New -- placement still forming; expect specialty or excluded on weight-loss-excluded plans | Bridge-eligible (all formulations) at $50/mo from July 1, 2026 |
| Compounded semaglutide / tirzepatide | Not FDA-approved drug products | No formulary tier | Generally not insurance- or Medicare-covered; not Bridge-eligible |
Varies by plan; confirm your own number via member portal or the call script below. Never trust a generic internet answer — including this table — for your exact tier. Placement is a pattern, not a guarantee.
How do Medicare, Medicaid, FEHB, and employer plans handle GLP-1 tiers differently?
Your insurance type can matter as much as your medication. Some cover weight-loss GLP-1s broadly; some exclude them entirely; and Medicare is running a brand-new 2026 program that sidesteps the tier system for weight-loss use.
| Plan type | Weight-loss GLP-1 coverage | The thing to know |
|---|---|---|
| Employer / commercial | Highly variable -- many exclude weight-loss GLP-1s; diabetes use usually covered | Your employer's specific plan design decides it. The insurer's name alone won't tell you. |
| ACA Marketplace | Often limited for obesity; PA and quantity limits common | Marketplace formularies are public -- you can look yours up before enrolling. |
| FEHB (federal employees/retirees) | At least one weight-loss GLP-1 must be covered, plus two oral anti-obesity meds | A real coverage floor -- but which drug and tier vary, and a behavioral/nutrition program is usually required. |
| Medicare Part D (standard) | Excluded for weight-loss-only use; covered for other approved uses (diabetes, CV, sleep apnea, MASH) | Covered GLP-1s sit on a tier (commonly higher brand or specialty) with PA. |
| Medicare GLP-1 Bridge | Yes -- for eligible Part D members using Bridge-eligible drugs for weight management and meeting CMS criteria | Starts July 1, 2026 through Dec 31, 2027; runs outside Part D at a flat $50/month. |
| Medicaid | Varies by state -- about 13 states covered obesity GLP-1s as of January 2026 | A separate expansion is rolling out in participating states starting May 2026. |
| VA / TRICARE | Has its own formulary and rules | Check the specific program -- it doesn't follow commercial tiers. |
- Starts July 1, 2026, scheduled through December 31, 2027
- Drug maker provides medication at a net price of about $245/month; you pay a flat $50 copay
- Runs outside the Part D benefit — the $50 doesn’t touch your deductible and doesn’t count toward your true out-of-pocket total
- Eligible drugs: Foundayo, Wegovy (injection and tablets), and the Zepbound KwikPen — when used for weight management
- If your GLP-1 is for diabetes, sleep apnea, MASH, or CV risk: that’s a Part D lane, not the Bridge — the formulary tier still matters
Your GLP-1 is non-formulary, excluded, or denied — what do you actually do?
Do not assume your only option is paying full retail. You have five real moves, and the right one depends on why you got the no. Walk this short decision tree before you do anything else:
- Denied because of your diagnosis? -- You may need documentation for a covered use, or a different covered GLP-1.
- Excluded for weight loss specifically? -- Ask if it's excluded for all uses or just weight loss; a qualifying condition may change the answer.
- Missing prior authorization? -- Not a real denial yet. Your prescriber submits the PA with the right criteria.
- Wrong dose or NDC? -- A fixable paperwork mismatch at the pharmacy.
- Deductible not met? -- It may be "covered" but you're paying full price until you hit your deductible.
- Pharmacy ran the wrong benefit? -- Ask them to re-run it under your pharmacy benefit.
- Truly not on this plan's formulary? -- Time for a formulary exception, a different drug, or a cash-pay route.
| Your move | When to use it | Key caveat |
|---|---|---|
| Request a tier exception | Drug is covered but expensive; want a lower cost-share | Plan must agree the covered option isn't appropriate |
| File a formulary exception | Drug isn't on formulary at all; have a letter of medical necessity | Against a hard exclusion, this is a long shot |
| Use a manufacturer savings card | Commercially insured (not Medicare/Medicaid/VA/TRICARE) | Check card terms -- FEHB, ACA exchange, state-employee plans vary |
| Check Medicare GLP-1 Bridge | On Medicare, using GLP-1 for weight loss, meet CMS criteria | $50/month, July 2026--Dec 2027; only for weight-management use |
| Compare cash-pay telehealth | Insurance fails or coinsurance exceeds cash price | Often less than specialty-tier coinsurance; LillyDirect and Ro offer self-pay pricing |
When should you use Ro, your own doctor, or a cash-pay route?
Use a telehealth program like Ro when your real problem is the insurance maze itself. Use your own doctor if you already have a clinician who’ll happily file your PA. Use a manufacturer or cash-pay route when insurance fails or the cash price beats your specialty-tier coinsurance.
| Route | Best for | Timeline (Ro data) | Key cost |
|---|---|---|---|
| Ro (telehealth + insurance concierge) | Surviving the benefits check, PA paperwork, and denials | Cash: 1-2 weeks; insurance: ~2-3 weeks | $39 first month, then $149/mo (or ~$74/mo annual); medication separate |
| Your own doctor | You already have a clinician who'll file PA | Depends on your practice | Your existing copay / office visit cost |
| LillyDirect / manufacturer cash-pay | Foundayo (orforglipron) self-pay pricing | 1-2 days to pharmacy | $149-$349/mo by dose; $25/mo with commercial savings card |
| Cash-pay telehealth | Insurance fails or coinsurance > cash price | Varies by provider | Compare vs. your specialty coinsurance math above |
What to say when you call your insurance (the exact script)
The fastest way to get a real answer is to ask your plan about your exact drug, dose, diagnosis, pharmacy, and out-of-pocket cost — not just “Is Wegovy covered?” A vague question gets a technically-true but useless answer. Call the number on your prescription (pharmacy) card.
Say this word for word:
“Hi, I’m checking prescription coverage for [drug name + strength]. Using my member ID, can you tell me:
- Is it on my exact formulary?
- What tier is it?
- Is that tier a flat copay or a coinsurance percentage?
- Does my deductible apply first?
- What’s the estimated cost for a 28-day fill at [my pharmacy]?
- Is prior authorization required?
- What diagnosis criteria must be met?
- Is step therapy required, and what must I try first?
- Are there quantity limits by dose?
- If it’s non-formulary or excluded, can my prescriber file a formulary exception or appeal?”
What we actually verified for this guide
Last verified: . We verified insurance definitions, tier mechanics, GLP-1 coverage patterns, FDA approval status, FEHB coverage floor, and 2026 Medicare programs against public, authoritative sources. We did not verify your personal plan — use the call script for that.
| What we verified | Source | Status |
|---|---|---|
| Formulary = covered-drug list; tiers = cost levels; tiers vary by plan | HealthCare.gov; Medicare.gov | Verified (plan-variable) |
| GLP-1s on higher/specialty tiers; covered Marketplace GLP-1s commonly used PA/quantity limits | KFF Health System Tracker (2024 ACA Marketplace analysis) | Verified as plan-variable |
| Coinsurance math: ~$1,350 list x 25/30/33% = ~$337/$405/$445 | Calculation from list-price example; your plan's allowed amount may differ | Math example, not your price |
| ~43% of users had weight-loss GLP-1 coverage; ~half paid ≤$50/mo; PA common | Ro GLP-1 Insurance Coverage Checker report | Verified as Ro-stated data |
| Medicare Bridge: $50/mo, July 2026-Dec 2027, outside Part D, eligible drugs (Foundayo/Wegovy/Zepbound KwikPen), clinical criteria | CMS Medicare GLP-1 Bridge | Verified |
| ~13 states covered obesity GLP-1s via Medicaid as of Jan 2026 | KFF | Verified |
| FEHB: ≥1 weight-loss GLP-1 + 2 oral anti-obesity meds required; behavioral program generally required | OPM 2026 plan-year guidance | Verified |
| Foundayo (orforglipron) FDA-approved April 1, 2026 for obesity | FDA label; Eli Lilly | Verified |
| Compounded GLP-1s not FDA-approved | FDA (human drug compounding) | Verified |
| Ro pricing ($39 first/$149 ongoing/~$74 annual); coverage checker + concierge; LegitScript-certified | ro.co/weight-loss/pricing | Verified -- re-confirm on publish day |
GLP-1 formulary tier FAQ
- What does a GLP-1 formulary tier mean?
- A GLP-1 formulary tier is the cost level your insurance plan assigns to a GLP-1 medication. Lower tiers cost less; higher tiers (like specialty) cost more. It estimates your cost zone but does not, by itself, confirm your final price or approval.
- Does Tier 3 mean Wegovy or Zepbound is covered?
- Tier 3 usually means the drug is covered but in a higher-cost, non-preferred category -- and it often still requires prior authorization. Ask your plan for the exact 28-day cost and the PA criteria before assuming.
- Does Tier 4 or specialty tier mean my GLP-1 is denied?
- No. Tier 4 or specialty usually means high cost-sharing, not automatic denial. The real issue is whether your plan charges a flat copay or a percentage (coinsurance), which can make a covered drug very expensive.
- What does "non-formulary" mean for a GLP-1?
- Non-formulary means the drug isn't on your plan's covered list. You may still have a path through a formulary exception, a different covered GLP-1, a different plan, or a cash-pay option.
- Can a GLP-1 be covered and still cost over $1,000?
- Yes. If you haven't met your deductible, or your plan uses coinsurance on a specialty tier, a "covered" GLP-1 can still cost hundreds to over a thousand dollars a month.
- What's the difference between a tier exception and a formulary exception?
- A tier exception asks your plan to charge a covered drug at a lower tier's cost. A formulary exception asks your plan to cover a drug that isn't on its list at all, usually with a letter of medical necessity.
- Why does insurance cover Ozempic but not Wegovy?
- Coverage often depends on the FDA-approved use. Plans commonly cover diabetes-labeled GLP-1s like Ozempic while restricting or excluding weight-loss-labeled GLP-1s like Wegovy.
- Are compounded GLP-1s on a formulary tier?
- No. Compounded GLP-1s aren't on insurance formularies, so they have no tier and are generally not covered by insurance or Medicare. They're cash-pay, and they're not FDA-approved drug products.
- Does Medicare cover GLP-1s for weight loss in 2026?
- Standard Medicare Part D excludes GLP-1s used only for weight loss. But starting July 1, 2026, the Medicare GLP-1 Bridge gives eligible Part D beneficiaries who meet CMS clinical criteria access to eligible GLP-1s for weight management at $50 a month, outside the Part D tier system, scheduled through December 31, 2027.
- Can Ro check my GLP-1 formulary tier?
- Ro's free GLP-1 Insurance Coverage Checker uses your insurance details to check coverage and return a personalized report with your estimated cost and whether prior authorization is required, across several GLP-1 medications.
- Should I switch insurance plans just for a GLP-1 tier?
- Not on the tier alone. Compare premiums, deductibles, PA criteria, pharmacy rules, and out-of-pocket maximums first. The formulary tier is one factor in a much bigger plan decision.
Still not sure which GLP-1 program is right for you?
Answer a few quick questions about your insurance, budget, medication preference, and goals, and we’ll show you the most realistic next step — covered, cash-pay, or appeal — for your exact situation.
Get my personalized GLP-1 plan →Or check my GLP-1 insurance coverage on Ro → (sponsored affiliate link, opens in a new tab)Related guides
- → GLP-1 insurance coverage checker
- → Medicare GLP-1 Bridge program: full guide
- → Does Medicare cover Foundayo?
- → GLP-1 cost without insurance: 2026 cash prices
- → Foundayo cost without insurance
- → Best GLP-1 telehealth providers that accept insurance
- → GLP-1 providers that help with prior authorization
- → Free 60-second GLP-1 matching quiz
Sources
- CMS -- Medicare GLP-1 Bridge: Information for Medicare Beneficiaries (eligibility, $50 copay, ~$245 net price, eligible drugs, July 1, 2026-Dec 31, 2027, Part D vs. Bridge lanes)
- KFF / Peterson-KFF Health System Tracker -- insurer strategies for weight-loss drugs (Marketplace PA and utilization management); KFF -- Medicaid GLP-1 obesity coverage by state; KFF -- BALANCE Model and Medicare GLP-1 Bridge
- U.S. Office of Personnel Management -- FEHB plan-year guidance (weight-loss GLP-1 + oral anti-obesity coverage requirement)
- U.S. Food and Drug Administration -- Foundayo (orforglipron) approval and label; FDA prescribing information for Ozempic, Wegovy, Zepbound, Mounjaro, Rybelsus, Saxenda; FDA human drug compounding
- HealthCare.gov (formulary definition) and Medicare.gov (drug tiers / how drug plans work)
- Ro -- GLP-1 Insurance Coverage Checker report and weight-loss program/insurance/pricing pages